Trial
NCT06732258
Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Sichuan University
Collaborators
—
Condition
Extensive-stage Small-cell Lung Cancer
Intervention
Low-dose radiotherapy
Why stopped
Inorder to avoid the serious adverse effect of Toripalimab combining with Tifcemalimab, considering as the protection of participants.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-29